Zobrazeno 1 - 10
of 141
pro vyhledávání: '"J Sträter"'
Autor:
M. Faehling, K. Lehrach, S. Fallscheer, B. Schwenk, S. Kramberg, J. Sträter, S. Eschmann, M. Hetzel, F. Heinzelmann, R. Sätzler
Publikováno v:
Journal of Thoracic Oncology. 18:S108
Publikováno v:
Pneumologie. 71:S1-S125
Publikováno v:
Histopathology. 52:399-402
Autor:
Gail K. Adler, C Schwänen, Bernhard Radlwimmer, Thomas M. Gress, P Lichter, M Nessling, J Sträter, Heiko Fensterer, Manfred P. Lutz
Publikováno v:
Zeitschrift für Gastroenterologie. 41
Publikováno v:
Pneumologie. 68
Publikováno v:
Nephrology Dialysis Transplantation. 13:911-918
Background. Radiocontrast-induced nephropathy is a clinically important complication of invasive cardiological procedures. It has been associated with DNA fragmentation of renal tubular cells, which is a hallmark feature of programmed cell death (apo
Autor:
P. Möller, Carlo Bernasconi, Mario Lazzarino, Catherine Klersy, Marco Paulli, M. T. Rousset, E. Marra, J. Sträter, C. Manegold, Umberto Magrini, Umberto Gianelli, M. Gambacorta, L. Gargantini, T. Lavabre-Bertrand, Ester Orlandi
Publikováno v:
Scopus-Elsevier
PURPOSE To define clinicopathologic features, response to treatment, and prognostic factors of primary mediastinal B-cell lymphoma (MBL), a CD20+ tumor recognized as a distinct entity among non-Hodgkin's lymphomas (NHL). PATIENTS AND METHODS One hund
Publikováno v:
Der Pneumologe. 2:42-44
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 80(3)
Introduction Some patients with advanced NSCLC show prolonged disease stabilization on treatment with an EGFR-tyrosine kinase inhibitor (TKI) such as erlotinib. It is not clear how to treat patients who progress after prolonged response to erlotinib.
Autor:
M. Siech, D Henne-Bruns, D. Stehle, Bogdan Prokopczyk, Hans G. Beger, J. Sträter, Gerhard Leder, R. Muche
Publikováno v:
Zeitschrift für Gastroenterologie. 43